SKK
FLXN

Shepherd Kaplan Krochuk’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,428
Closed -$276K – 281
2017
Q3 		$276K Hold
11,428
– – 0.26% 127
2017
Q2 		$231K Hold
11,428
– – 0.14% 153
2017
Q1 		$308K Sell
11,428
-4,004
-26% -$81.7K 0.16% 125
2016
Q4 		$294K Sell
15,432
-26,323
-63% -$503K 0.09% 132
2016
Q3 		$816K Hold
41,755
– – 0.18% 73
2016
Q2 		$625K Buy
+41,755
New +$525K 0.16% 88
2015
Q2 		– Sell
-14,378
Closed -$324K – 477
2015
Q1 		$324K Buy
+14,378
New +$333K 0.06% 226

Other funds holding FLXN

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.6B AUM 47.77% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return